Barr settles antitrust lawsuit over Ovcon for $5.9M

Generic-drug maker Barr Pharmaceuticals will pay $5.9 million to end an antitrust lawsuit filed by 34 states over claims that it received $20 million to hold off on marketing its version of Warner Chilcott Ltd.'s Ovcon, an oral contraceptive. Under the terms of the settlement, Barr is prohibited from entering into noncompetition agreements with firms that market brand name treatments for the next decade. A spokeswoman for Barr denied any wrongdoing, saying that the company still deems the deal with Warner Chilcott "legal, legitimate and pro-competitive."

View Full Article in:

California Chronicle (Los Angeles) · Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ